about
Modeling and Simulation Approaches for Cardiovascular Function and Their Role in Safety AssessmentAgent-based modeling: a systematic assessment of use cases and requirements for enhancing pharmaceutical research and development productivityModeling and simulation at the interface of nonclinical and early clinical drug developmentWhite paper: landscape on technical and conceptual requirements and competence framework in drug/disease modeling and simulation.Evaluation of estimation methods and power of tests of discrete covariates in repeated time-to-event parametric models: application to Gaucher patients treated by imiglucerase.Implementation of quantitative and systems pharmacology in large pharma.Integrating Multiple Evidence Sources to Predict Adverse Drug Reactions Based on a Systems Pharmacology Model.Effect of Kidney Function on Drug Kinetics and Dosing in Neonates, Infants, and ChildrenParsing interindividual drug variability: an emerging role for systems pharmacology.A model qualification method for mechanistic physiological QSP models to support model-informed drug development.Influence of the Size of Cohorts in Adaptive Design for Nonlinear Mixed Effects Models: An Evaluation by Simulation for a Pharmacokinetic and Pharmacodynamic Model for a Biomarker in OncologyPharmacometrics and Systems Pharmacology Software Tutorials and Use: Comments and Guidelines for PSP Contributions.Mathematical modeling and simulation in animal health. Part I: Moving beyond pharmacokinetics.Pharmacometric Approaches to Personalize Use of Primarily Renally Eliminated Antibiotics in Preterm and Term Neonates.Quantitative clinical pharmacology practice for optimal use of antibiotics during the neonatal period.Multiscale Modeling in the Clinic: Drug Design and DevelopmentCPT: Pharmacometrics & Systems Pharmacology Publishes Its 100th Article.Systems pharmacology of the nerve growth factor pathway: use of a systems biology model for the identification of key drug targets using sensitivity analysis and the integration of physiology and pharmacology.Advancing pharmacometrics and systems pharmacology.The Role of Modeling and Simulation in Development and Registration of Medicinal Products: Output From the EFPIA/EMA Modeling and Simulation WorkshopRegulatory modeling and simulation moves into the next gear in europe.Systems Pharmacology of the NGF Signaling Through p75 and TrkA Receptors.Systems approaches evolve clinical pharmacology.Tutorials on the foundations of pharmacometrics and systems pharmacology.What Pharmacometricians (Should) Do.Dose/Exposure-Response Modeling to Support Dosing Recommendation for Phase III Development of Baricitinib in Patients with Rheumatoid Arthritis.
P2860
Q26801610-CC024FF9-7CF7-4B86-B864-EA2C456EAA94Q27028010-591B9BF7-FB88-4662-BE3C-49903CFF2414Q28709672-9BF49371-E53A-41FF-9DC6-F111E70DAE8FQ30540355-CB2079F6-E76A-4E1F-A643-96C7501644B7Q33574132-7AA4CBD9-C3C8-47C2-B901-3A744DBCBCBDQ35760137-B9C63156-8AFD-4D45-8CF4-E0A40BD9DF02Q36118289-05932F11-2F92-4BB6-85FB-4FE91D41AEDAQ36322918-32D8CD7F-4EFD-48D8-B59F-C693906384E2Q36417380-88FD8C6A-3BF4-468B-B552-03F9F89A30D1Q36600060-49F54296-ACDD-4029-9FF3-29CD1A316CB3Q37742653-35D291E3-82DC-434A-9ADA-92FD69DFBE89Q38172404-82AD5A8F-96FB-4693-94BB-70488B7F9081Q38642539-065706C4-34AC-465B-932E-431806D8B823Q38696468-61CF9F27-830E-40D0-A105-5BE9369C7CAAQ38714060-A7ED1604-623C-4591-B352-20559C02751EQ38736948-821BC7C8-2C66-4B53-950E-65D8058911C2Q40093478-88C8D59C-8A60-4B0F-AE56-6F9BCD00645CQ40186234-69621FF7-6477-4866-A815-1109DE14F0C6Q41214689-0C4E492B-5CBF-4DFD-9E62-F12A1CDB7C15Q41980150-8B076700-8092-4D25-8931-612ED7776741Q41991129-3A87CA94-F437-4A51-B97A-8EFD71F6739CQ42110905-FD5D922B-4C2D-40A5-B502-2C52BD7AF235Q42906573-037FA7F9-991B-4410-B466-1BC510E9256FQ43063500-2AFB24A9-66A0-47C5-AAAF-77D73C55F081Q46598955-2406C89C-0BCF-4B89-BA98-0693DAE75426Q47103417-A928059C-5F9C-48BC-9AA9-9AE242A4B284
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
CPT: Pharmacometrics and Systems Pharmacology
@ast
CPT: Pharmacometrics and Systems Pharmacology
@en
CPT: Pharmacometrics and Systems Pharmacology
@nl
type
label
CPT: Pharmacometrics and Systems Pharmacology
@ast
CPT: Pharmacometrics and Systems Pharmacology
@en
CPT: Pharmacometrics and Systems Pharmacology
@nl
prefLabel
CPT: Pharmacometrics and Systems Pharmacology
@ast
CPT: Pharmacometrics and Systems Pharmacology
@en
CPT: Pharmacometrics and Systems Pharmacology
@nl
P2860
P356
P1476
CPT: Pharmacometrics and Systems Pharmacology
@en
P2093
Piet H van der Graaf
P2860
P356
10.1038/PSP.2012.8
P407
P577
2012-09-26T00:00:00Z